Latest News

Follow Adapet’s journey as we expand globally and shape the future of pet diabetes care.

News

September 2023 – Initial Prototype Testing Begins

Adapet began its journey in revolutionizing pet diabetes care by initiating internal prototype testing for its Continuous Glucose Monitoring (CGM) system. This phase focused on validating the core sensor technology,...

September 2023 – Initial Prototype Testing Begins

Adapet began its journey in revolutionizing pet diabetes care by initiating internal prototype testing for its Continuous Glucose Monitoring (CGM) system. This phase focused on validating the core sensor technology,...

March 2024 – First Clinical Trial (Phase I) Lau...

Adapet officially launched its Phase I clinical usability and safety study, involving a select group of diabetic dogs under veterinary supervision. The trial aimed to explore the user experience from...

March 2024 – First Clinical Trial (Phase I) Lau...

Adapet officially launched its Phase I clinical usability and safety study, involving a select group of diabetic dogs under veterinary supervision. The trial aimed to explore the user experience from...

August–September 2024 – Blind-Wear Tests & Pack...

With its prototype refined, Adapet conducted blind-wear tests in veterinary hospitals, focusing on long-duration wear, motion friction response, skin sensitivity, and behavior observation. At the same time, the product’s visual...

August–September 2024 – Blind-Wear Tests & Pack...

With its prototype refined, Adapet conducted blind-wear tests in veterinary hospitals, focusing on long-duration wear, motion friction response, skin sensitivity, and behavior observation. At the same time, the product’s visual...

September 2024 – APP Development Structure Conf...

Adapet’s digital companion—the CGM mobile app—entered its full-stack development phase. The company defined a modular development approach, assigning responsibilities to Jiunuo for UI/UX, backend integration for real-time sensor data, and...

September 2024 – APP Development Structure Conf...

Adapet’s digital companion—the CGM mobile app—entered its full-stack development phase. The company defined a modular development approach, assigning responsibilities to Jiunuo for UI/UX, backend integration for real-time sensor data, and...

September–October 2024 – Phase II Clinical Tria...

In this critical clinical validation stage, Adapet initiated multi-week trials with 5–10 diabetic dogs and cats, using the CGM device in daily living conditions while collecting comparative BGM data. The...

September–October 2024 – Phase II Clinical Tria...

In this critical clinical validation stage, Adapet initiated multi-week trials with 5–10 diabetic dogs and cats, using the CGM device in daily living conditions while collecting comparative BGM data. The...

November 2024 – Clinical Protocol Finalized for...

Adapet’s medical and scientific teams finalized the standard operating procedures (SOPs) and data frameworks for the upcoming Phase III clinical trial. This included protocols for multi-center testing, data anonymization, baseline...

November 2024 – Clinical Protocol Finalized for...

Adapet’s medical and scientific teams finalized the standard operating procedures (SOPs) and data frameworks for the upcoming Phase III clinical trial. This included protocols for multi-center testing, data anonymization, baseline...